Zobrazeno 1 - 10
of 89
pro vyhledávání: '"Haresh, Kp"'
Autor:
Rishabh Jain, Akash Kumar, Atul Sharma, Ranjit Kumar Sahoo, Aparna Sharma, Amlesh Seth, Brusabhanu Nayak, Shamim A Shamim, Seema Kaushal, Haresh KP, Chandan J Das, Atul Batra
Publikováno v:
JMIR Research Protocols, Vol 13, p e54086 (2024)
BackgroundApproximately 20%-25% of patients with metastatic castration-resistant prostate cancer (mCRPC) harbor a deleterious germline or somatic mutation in the homologous recombination repair (HRR) pathway genes, which is involved in the repair of
Externí odkaz:
https://doaj.org/article/f7da98dec4154f32aeb1b67e3eab4505
Autor:
Verma, Saurav, Arora, Shalabh, Sahoo, Ranjit Kumar, Singh, Prabhjot, Nayak, Brusabhanu, Haresh, KP, Das, Chandan J, Shamim, Shamim A, Kaushal, Seema, Batra, Atul
Publikováno v:
In Cancer Treatment and Research Communications 2022 31
Autor:
Neha Pathak, Abhishek Raj, Akhil Santhosh, Sudhir Kumar, Haresh KP, Prabhjot Singh, Shamim Shamim, Amlesh Seth, Mukurdipi Ray, Seema Kaushal, Ranjit Sahoo, Atul Batra
Purpose: Patients with Germ cell tumours (GCT) are at risk of long-term toxicities due to multimodality therapy. It is debatable whether there is an impact on the quality of life(QoL) of GCT survivors. Methods: A case-control study was conducted at a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8160e26a7243daeb319437f4c97a97d1
https://doi.org/10.21203/rs.3.rs-2540868/v1
https://doi.org/10.21203/rs.3.rs-2540868/v1
Autor:
Sushant, Sushant, Radhakrishnan, Ragavi, Haresh, KP, Anjali, VR, Sharma, Aparna, Sharma, Atul, Kaushal, Seema
Publikováno v:
In Brachytherapy November-December 2024 23(6) Supplement:S132-S132
Autor:
Vibhay Pareek, Subhash Gupta, Haresh KP, Prashanth Giridhar, Bharti Devnani, Pramod Kumar Julka
Publikováno v:
WFNOS 2022 Abstract Book.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ca4721dcf876584a0257c47a5cd03414
https://doi.org/10.14791/btrt.2022.10.f-2726
https://doi.org/10.14791/btrt.2022.10.f-2726
Autor:
Neha Pathak, Sudhir Kumar, Abhishek Raj, Ranjit Kumar Sahoo, Haresh KP, Prabhjot Singh, Shamim Ahmed Shamim, Amlesh Seth, M D Ray, Seema Kaushal, Chandan Krushna Das, Atul Batra
Publikováno v:
Journal of Clinical Oncology. 41:415-415
415 Background: Testicular germ cell tumors (t-GCTs) commonly present in age group 20-40 years (yrs). Older patients (pts) in many cancers have worse tolerance to therapy and outcomes. We examine herein the effect of older age in t-GCT pts. Methods:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f839e56ee10e6dfbadb8266e9d5e759a
https://doi.org/10.1200/jco.2023.41.6_suppl.415
https://doi.org/10.1200/jco.2023.41.6_suppl.415
Autor:
ANKUR NANDAN VARSHNEY, Abhishek Raj, Ranjit Kumar Sahoo, Haresh KP, Prabhjot Singh, Shamim Ahmed Shamim, Amlesh Seth, M D INDIA INSTITUTE OF MEDICAL Ray, Seema Kaushal, Chandan Krushna Das, Atul Batra
Publikováno v:
Journal of Clinical Oncology. 40:5036-5036
5036 Background: Testicular GCT is a rare malignancy, with excellent outcomes. However, approximately one-fourth of intermediate risk and half of the patients with poor risk disease succumb to recurrent GCT. We looked at the prognostic significance o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::451ae5f63a79d2a67995022a9620ad34
https://doi.org/10.1200/jco.2022.40.16_suppl.5036
https://doi.org/10.1200/jco.2022.40.16_suppl.5036
Autor:
Haresh Kp, Sreedharan Thankarajan Arunraj, Arunav Kumar, Subhash Gupta, Nikhil Mohan, Chandrasekhar Bal, Madhavi Tripathi
Publikováno v:
Clinical nuclear medicine. 46(5)
We describe the utility of molecular imaging with 18F-FDG and 68Ga-DOTANOC PET for treatment response assessment in a case of metastatic medulloblastoma. 18F-FDG and 68Ga-DOTANOC PET/CT revealed extensive metastases to bone and bone marrow. Patient s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f732d7c76695b9586a9017ce917dc8cc
https://pubmed.ncbi.nlm.nih.gov/33315670
https://pubmed.ncbi.nlm.nih.gov/33315670
Autor:
Haresh KP, Egils Vjaters, Daniel Castellano, David Olmos, Neal D. Shore, Liina Nevalaita, Isabella Testa, Christian Kappeler, Iris Kuss, Fred Saad
Publikováno v:
Journal of Clinical Oncology. 40:TPS200-TPS200
TPS200 Background: Previous randomized, phase 3 trials have shown the efficacy of adding docetaxel, abiraterone acetate, enzalutamide, or apalutamide to ADT in improving overall survival and/or radiologic progression-free survival (rPFS) in patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f9ef098d7b76ad5654d7c8521fb95cb8
https://doi.org/10.1200/jco.2022.40.6_suppl.tps200
https://doi.org/10.1200/jco.2022.40.6_suppl.tps200
Autor:
ANKUR NANDAN VARSHNEY, Abhishek Raj, Prabhjot Singh, Brusabhanu Nayak, Haresh KP, Ranjit Kumar Sahoo, Atul Batra
Publikováno v:
Journal of Clinical Oncology. 40:413-413
413 Background: Testicular NSGCT is typically diagnosed in young males, and is a highly curable cancer. Data pertaining to the quality of life of testicular NSGCT survivors are limited. Methods: Patients aged 18 or more years with a diagnosis of test
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b746f786956258ea00219990d130a98e
https://doi.org/10.1200/jco.2022.40.6_suppl.413
https://doi.org/10.1200/jco.2022.40.6_suppl.413